The sequencing consumables market would grow at a CAGR of 18.14% over the predicted time frame. The market is expected to increase in value from US$ 6.94 billion in 2023 to US$ 50.75 billion by 2033.
Key Takeaways
- Asia Pacific is expected to witness the fastest rate of growth in the sequencing consumables market during the forecast period.
- By product, the kits segment held the largest segment of the sequencing consumables market in 2023.
- By product, the reagents segment is expected to grow at a significant rate during the forecast period.
- By platform, the second-generation sequencing consumables segment is expected to hold the dominating share of the market.
- By platform, the third-generation sequencing consumables segment is expected to grow at a notable rate.
- By application, the cancer diagnostics segment is expected to hold the dominating share of the market during the forecast period.
- By application, the pharmacogenomics segment is expected to grow at a notable rate.
The on sequencing consumables Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.
Download Free Sample@ https://www.precedenceresearch.com/sample/3679
A recent report provides crucial insights along with application based and forecast information in the Global Sequencing consumables Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Sequencing consumables market.
A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.
Sequencing Consumables Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 18.14% |
| Global Market Size in 2023 | USD 6.94 Billion |
| Global Market Size by 2033 | USD 50.75 Billion |
| U.S. Market Size in 2023 | USD 2.53 Billion |
| U.S.Market Size by 2033 | USD 13.39 Billion |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Product, By Platform, and By Application |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Read Also: Plastic Processing Machinery Market Size to Cross USD 35.58 Bn By 2033
Companies and Manufacturers Covered
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Sequencing consumables market are included as given below:
Recent developments in the Sequencing Consumables Market
- In October 2022, Illumina (US) collaborated with GenoScreen (France) to extend genomic testing accessibility for multidrug-resistant tuberculosis, particularly in countries heavily affected by tuberculosis. This partnership aims to enhance diagnostic capabilities and contribute to the global effort to combat tuberculosis.
- In October 2022, Illumina (US) entered into a strategic research collaboration with AstraZeneca (UK). The partnership focuses on improving pharmaceutical pipelines by leveraging genomic insights to identify genetic variants associated with human diseases. This collaboration underscores the increasing importance of genomics in drug development and precision medicine.
- In September 2022, Thermo Fisher Scientific (US) achieved FDA approval for the Oncomine Dx Target Test. This marked a milestone as the first Next-Generation Sequencing (NGS)-based companion diagnostic, designed to aid in therapy selection for patients with RET mutations/fusions in thyroid cancers. The FDA approval highlights the growing role of genomics in guiding personalized treatment decisions for cancer patients.
Sequencing Consumables Market Companies
- Illumina, Inc. (US)
- Thermo Fisher Scientific Inc. (US)
- Qiagen N.V. (Netherlands)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Agilent Technologies, Inc. (US)
- Pacific Biosciences of California, Inc. (US)
- PerkinElmer, Inc. (US)
- Oxford Nanopore Technologies Ltd. (UK)
- Bio-Rad Laboratories, Inc. (US)
- BGI Genomics Co., Ltd. (China)
- GenScript Biotech Corporation (China)
- Eurofins Scientific (Luxembourg)
- Macrogen Inc. (South Korea)
- New England Biolabs, Inc. (US)
- Swift Biosciences, Inc. (US)
Segments Covered in the Report
By Product
- Kits
- Reagents
- Accessories
By Platform
- 1st Generation sequencing consumables
- 2nd Generation sequencing consumables
- 3rd Generation sequencing consumables
By Application
- Cancer Diagnostics
- Infectious Disease Diagnostics
- Reproductive Health Diagnostics
- Pharmacogenomics
- Agrigenomics
- Others
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Report Objectives
- To define, describe, and forecast the global sequencing consumables market based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the sequencing consumables market
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Sequencing Consumables Market
5.1. COVID-19 Landscape: Sequencing Consumables Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Sequencing Consumables Market, By Product
8.1. Sequencing Consumables Market Revenue and Volume, by Product, 2024-2033
8.1.1 Kits
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Reagents
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
8.1.3. Accessories
8.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Sequencing Consumables Market, By Platform
9.1. Sequencing Consumables Market Revenue and Volume, by Platform, 2024-2033
9.1.1. 1st Generation sequencing consumables
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. 2nd Generation sequencing consumables
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
9.1.3. 3rd Generation sequencing consumables
9.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Sequencing Consumables Market, By Application
10.1. Sequencing Consumables Market Revenue and Volume, by Application, 2024-2033
10.1.1. Cancer Diagnostics
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Infectious Disease Diagnostics
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Reproductive Health Diagnostics
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Pharmacogenomics
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
10.1.5. Agrigenomics
10.1.5.1. Market Revenue and Volume Forecast (2021-2033)
10.1.6. Others
10.1.6.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Sequencing Consumables Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.1.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.1.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.1.4.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.1.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.1.5.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.1.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.2.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.4.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.2.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.5.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.2.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.6.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.2.7.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.2.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.3.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.4.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.3.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.5.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.3.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.6.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.3.7.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.3.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.4.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.4.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.5.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.4.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.6.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.4.7.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.4.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.5.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.5.4.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.5.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Product (2021-2033)
11.5.5.2. Market Revenue and Volume Forecast, by Platform (2021-2033)
11.5.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
Chapter 12. Company Profiles
12.1. Illumina, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Thermo Fisher Scientific Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Qiagen N.V
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. F. Hoffmann-La Roche Ltd.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Agilent Technologies, Inc
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Pacific Biosciences of California, Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. PerkinElmer, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Oxford Nanopore Technologies Ltd.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Bio-Rad Laboratories, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. BGI Genomics Co., Ltd.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com